Results 151 to 160 of about 38,804 (267)

A Rare Case of Cutaneous Metastasis From Oral Squamous Cell Carcinoma (OSCC) and the Possible Role of GALR2 as a Biomarker: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT We report a rare case of cutaneous metastasis from oral squamous cell carcinoma (OSCC). The primary tumor showed low expression of Galanin, CD68, GALR2, and Collagen IV, with increased FOXP3 and Vimentin. Systemic analysis revealed reduced CD8+ cells and increased Tregs. The patient died following aggressive disease progression.
Ianny Brum Reis   +9 more
wiley   +1 more source

Linfoma no Hodgkin con localización extranodal nasosinusal.

open access: yes, 1996
Se presenta un caso clínico de un paciente diagnosticado en nuestro servicio de LNH naosinusal extranodal haciendo una revisión bibliográfica de esta patología desde el punto de vista del diagnóstico, pronóstico y ...
Acevedo, R.   +4 more
core  

Idiopathic Multicentric Castleman Disease Associated With Seronegative Erosive Chronic Polyarthritis: A Diagnostic Challenge

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Idiopathic multicentric Castleman disease can rarely present with systemic inflammation and erosive seronegative polyarthritis. Awareness of this association helps prevent misdiagnosis and ensures appropriate immunosuppressive management based on clinicopathological and immunohistochemical correlation.
Birahim Lo   +9 more
wiley   +1 more source

Cutaneous extranodal natural killer/T-cell lymphoma mimicking cellulitis: A unique presentation

open access: yesJAAD Case Reports, 2020
Ali Duffens, BS   +3 more
doaj   +1 more source

Paraneoplastic Myopathy as a Possible Initial Presentation of Sporadic Burkitt Lymphoma in an Immunocompetent Adult: A Case Report

open access: yesCancer Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background Burkitt's lymphoma (BL) is a highly aggressive B‐cell non‐Hodgkin lymphoma with rapid proliferation and early systemic dissemination. Neuromuscular manifestations are rare and are typically secondary to direct infiltration or metabolic complications.
Abolfazl Khalafi‐Nezhad   +3 more
wiley   +1 more source

Durable Intracranial Response to Sacituzumab Tirumotecan in HER2‐Negative Salivary Duct Carcinoma With High TROP2 Expression: A Case Report

open access: yesCancer Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background Salivary duct carcinoma is an aggressive salivary gland malignancy in which systemic therapy is often guided by androgen receptor and HER2 status. Treatment options are limited for HER2‐negative disease after progression on androgen‐deprivation therapy and chemotherapy, particularly when active central nervous system (CNS ...
Guang‐Liang Chen   +5 more
wiley   +1 more source

A patient with a papulo‐nodular lesion on the shoulder

open access: yesJEADV Clinical Practice, 2023
Fanny Ickx   +4 more
doaj   +1 more source

Prognostic Factor Analysis for Risk‐Stratified Papillary Thyroid Carcinoma and Nomogram Development for Predicting Structural Incomplete Response to Radioactive Iodine Therapy in Intermediate‐Risk Patients

open access: yesCancer Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background Structural incomplete response (SIR) after radioactive iodine (RAI) therapy indicates persistent or recurrent structural disease and has important implications for the long‐term management of patients with papillary thyroid carcinoma (PTC).
Yamin Li   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy